Vortrag am FONDS professionell KONGRESSAbaris Biotechnology Opportunities A EUR
| MVD-Fonds Rating | EDA |
|---|---|
  | - |
ISIN: LU2210105669 | WKN: A2QAAS
KAG: Hauck & Aufhäuser
NAV: 52,00 EUR am 29.04.2025
Portfolio
Watchlist
KursalarmChart
Kennzahlen Abaris Biotechnology Opportunities A EUR
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | -5,64% | -28,97% | -19,70% | -10,94% | - | - | -48,00% |
| Volatilität | +65,34% | +44,08% | +38,71% | +41,62% | - | - | +39,89% |
| Sharpe Ratio | -0,83 | -1,18 | -0,57 | -0,14 | - | - | -0,40 |
| Bester Monat | - | +4,68% | +10,80% | +38,44% | +38,44% | - | +38,44% |
| Schl. Monat | - | -13,23% | -13,23% | -18,09% | -24,15% | - | -24,15% |
| Max. Verlust | -21,45% | -43,68% | -43,68% | -48,45% | - | - | -71,73% |
Monatsperformance Abaris Biotechnology Opportunities A EUR
| 2025 | 2024 | 2023 | 2022 | 2021 | |
| Januar | +4,37% | +0,70% | +13,48% | -24,15% | +7,93% |
| Februar | -5,60% | +38,44% | -5,60% | +2,59% | -2,72% |
| März | -13,23% | -6,06% | -12,56% | +4,23% | -8,89% |
| April | -5,64% | -12,69% | +3,22% | -15,34% | +1,73% |
| Mai | - | -1,95% | +6,96% | -18,09% | -8,80% |
| Juni | - | -2,00% | -2,86% | +9,58% | +8,90% |
| Juli | - | +10,80% | +2,34% | +14,69% | -7,89% |
| August | - | -2,17% | -7,78% | +2,56% | +4,55% |
| September | - | -1,78% | -7,20% | -4,59% | -3,97% |
| Oktober | - | +4,67% | -17,55% | -2,60% | +1,19% |
| November | - | +4,68% | +18,37% | -9,71% | -12,08% |
| Dezember | - | -12,45% | +30,90% | -1,18% | -0,29% |
| Gesamt | -19,33% | +12,21% | +12,40% | -39,89% | -20,71% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (Abaris Biotechnology Opportunities) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Biotechnologie) weltweit in EUR:
Fonds vergleichenWeitere ähnliche Fonds